DDAVP 0.2 RPR
Generic Name: desmopressin
Pill imprint DDAVP 0.2 RPR has been identified as Ddavp 0.2 mg.
DDAVP is used in the treatment of diabetes insipidus; von willebrand's disease; hemophilia a; primary nocturnal enuresis and belongs to the drug class antidiuretic hormones. There is no proven risk in humans during pregnancy.
DDAVP 0.2 mg is not subject to the Controlled Substances Act.
See also related documents.
Ddavp Images
- Generic Name:
- desmopressin
- Imprint:
-
DDAVP 0.2
RPR - Strength:
- 0.2 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose
potato starch
magnesium stearate
povidone
- Drug Class:
- Antidiuretic hormones
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aventis Pharmaceuticals
- National Drug Code (NDC):
- 00075-0026
Advertisement
More DDAVP resources
- DDAVP (Wolters Kluwer)
- DDAVP Solution (Wolters Kluwer)
- DDAVP Spray (Wolters Kluwer)
- DDAVP Tube (Wolters Kluwer)
- DDAVP (Cerner Multum)
- DDAVP injection (Cerner Multum)
- DDAVP nasal (Cerner Multum)
- DDAVP (Micromedex) - Includes Dosage Information
- DDAVP (FDA)
- DDAVP Rhinal Tube (FDA)
- DDAVP Tablets (FDA)
Search Again
